Dr. Yi-Bin Chen, MD
Claim this profileMassachusetts General Hospital
Area of expertise
Acute Myeloid Leukemia
Yi-Bin Chen, MD has run 6 trials for Acute Myeloid Leukemia. Some of their research focus areas include:
Acute Lymphoblastic Leukemia
Yi-Bin Chen, MD has run 4 trials for Acute Lymphoblastic Leukemia. Some of their research focus areas include:
Affiliated Hospitals
Massachusetts General Hospital
Massachusetts
Clinical Trials Yi-Bin Chen, MD is currently running
Experimental Drug
for Leukemia Post-Stem Cell Transplant
This is a multi-center, non-randomized, concurrent controlled, multi-arm, Phase 1 interventional, open-label, biologic assignment-based umbrella study evaluating the feasibility, safety and preliminary efficacy of an escalating dose regimen of up to 2 doses of TSC-100 and TSC-101 in patients with AML, MDS, or ALL following HCT from a haploidentical donor, MMUD, or MUD
Recruiting
1 award
Phase 1
Unlicensed Cord Blood Transplant
for Blood/Immune System Disorders
This trial is testing the safety of giving patients special blood from umbilical cords. The study focuses on patients who receive these infusions to see if there are any serious side effects. The cord blood has special cells that can help make new blood cells in the body. Umbilical cord blood has been used in the treatment of various diseases for many years, including leukemia, lymphoma, and congenital immunodeficiency.
Recruiting
1 award
Phase 2
1 criteria
More about Yi-Bin Chen, MD
Clinical Trial Related
9 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Yi-Bin Chen, MD has experience with
- Orca-T
- Fludarabine
- Cyclosporins
- Tacrolimus
- Alemtuzumab
- Mycophenolate Mofetil
Breakdown of trials Yi-Bin Chen, MD has run
Acute Myeloid Leukemia
Acute Lymphoblastic Leukemia
Myelodysplastic Syndrome
Aplastic Anemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Yi-Bin Chen, MD specialize in?
Yi-Bin Chen, MD focuses on Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia. In particular, much of their work with Acute Myeloid Leukemia has involved HLA-A positive patients, or patients who are HLA-A negative.
Is Yi-Bin Chen, MD currently recruiting for clinical trials?
Yes, Yi-Bin Chen, MD is currently recruiting for 3 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Yi-Bin Chen, MD has studied deeply?
Yes, Yi-Bin Chen, MD has studied treatments such as Orca-T, Fludarabine, Cyclosporins.
What is the best way to schedule an appointment with Yi-Bin Chen, MD?
Apply for one of the trials that Yi-Bin Chen, MD is conducting.
What is the office address of Yi-Bin Chen, MD?
The office of Yi-Bin Chen, MD is located at: Massachusetts General Hospital, Boston, Massachusetts 02114 United States. This is the address for their practice at the Massachusetts General Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.